Publication | Closed Access

A combination of a fixed dose rate infusion of gemcitabine associated to a bolus 5-fluorouracil in advanced pancreatic cancer, a report from the Italian Group for the Study of Digestive Tract Cancer (GISCAD)

OncologyPancreatic CancerGastrointestinal OncologyMedicineGastroenterologyItalian GroupDigestive Tract CancerCancer TreatmentPharmacologyRadiation OncologyDose Rate Infusion